ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,192.00
      -0.44%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.83
      0.35%
      Bitcoin
      62,636.15
      -0.34%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Verastem Inc (VSTM)

      7. Verastem Inc (VSTM) News

      VSTM

      Verastem (VSTM)

      Verastem Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VSTM
      DateTimeSourceHeadlineSymbolCompany
      02/12/20214:47PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VSTMVerastem Inc
      02/12/20214:47PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VSTMVerastem Inc
      02/11/20214:23PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VSTMVerastem Inc
      02/10/202112:15PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VSTMVerastem Inc
      02/05/20218:17AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VSTMVerastem Inc
      02/02/20213:21PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VSTMVerastem Inc
      01/20/20218:00AMBusiness WireFrank Neumann, M.D., Ph.D., to Depart Verastem OncologyNASDAQ:VSTMVerastem Inc
      01/08/20211:22PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VSTMVerastem Inc
      01/08/202112:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
      01/08/202112:20PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VSTMVerastem Inc
      01/07/20214:05PMBusiness WireVerastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VSTMVerastem Inc
      01/06/20219:13AMBusiness WireVerastem Oncology Appoints Frank Neumann, M.D., Ph.D., as Chief Medical OfficerNASDAQ:VSTMVerastem Inc
      01/05/20217:00AMBusiness WireVerastem Oncology to Present at the H.C. Wainwright BioConnect 2021 ConferenceNASDAQ:VSTMVerastem Inc
      12/22/20201:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
      12/22/20201:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
      12/17/20209:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
      12/15/20207:00AMBusiness WireVerastem Oncology Initiates Phase 2 Registration-Directed Trial of VS-6766 & Defactinib in Previously Treated KRAS Mutant Non...NASDAQ:VSTMVerastem Inc
      11/30/20207:00AMBusiness WireVerastem Oncology Initiates Phase 2 Registration-Directed Trial of VS-6766 & Defactinib in Recurrent Low-Grade Serous Ovarian...NASDAQ:VSTMVerastem Inc
      11/09/20204:37PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VSTMVerastem Inc
      11/09/20204:05PMBusiness WireVerastem Oncology Reports Third Quarter 2020 Financial Results and Highlights Recent Company ProgressNASDAQ:VSTMVerastem Inc
      10/28/20208:01PMBusiness WireVerastem Oncology Announces New Data Published in The Lancet Oncology Supports Potential of VS-6766 as Treatment for RAS Muta...NASDAQ:VSTMVerastem Inc
      10/06/20207:00AMBusiness WireVerastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VSTMVerastem Inc
      09/30/20209:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
      09/30/20208:54AMBusiness WireVerastem Oncology Announces Closing of COPIKTRA® (duvelisib) Sale to Secura BioNASDAQ:VSTMVerastem Inc
      09/16/20208:51AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
      09/16/20207:00AMBusiness WireVerastem Oncology Announces Presentation of Updated Phase 1/2 FRAME Study Data at the 2nd Annual RAS-Targeted Drug Developmen...NASDAQ:VSTMVerastem Inc
      09/14/20207:00AMBusiness WireVerastem Oncology Announces Investor Conference Call to Discuss Updated Clinical Data in Low-Grade Serous Ovarian Cancer from...NASDAQ:VSTMVerastem Inc
      09/10/20204:05PMBusiness WireVerastem Oncology to Present at Upcoming Investor ConferencesNASDAQ:VSTMVerastem Inc
      08/13/20204:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
      08/13/202012:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
       Showing the most relevant articles for your search:NASDAQ:VSTM